Alnylam Pharmaceuticals announced it will present new clinical data at the European Society of Cardiology Congress in Madrid, Spain.
2 reports, 2 independent
Updated Aug 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alnylam Pharmaceuticals announced it will present new clinical data at the European Society of Cardiology Congress in Madrid, Spain.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
Nothing else this week.
-
European Society of Cardiology
non-profit knowledge-based professional association
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- finanznachrichten.de
- Business WireAlnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025 - Company to Webcast Investor Event on Augus